Midodrine: A selective cc-adrenergic agonist for orthostatic hypotension and dialysis hypotension

Expert Opinion on Pharmacotherapy

Volumn 1, Issue 4, 2000, Pages 835-840

  Cruz, Dinna N ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

A adrenergic agonist; Dialysis hypotension; Midodrine (pro amatine); Orthostatic hypotension

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; MIDODRINE;

HUMAN; HYPOTENSION; ORTHOSTATIC HYPOTENSION; RENAL REPLACEMENT THERAPY; REVIEW;

ADRENERGIC ALPHA-AGONISTS; HUMANS; HYPOTENSION; HYPOTENSION, ORTHOSTATIC; MIDODRINE; RENAL DIALYSIS;

EID: 0034189059     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.1.4.835     Document Type: Article

References (36)

1. KAUFFMAN H, BRANNAN T, KRAKOFF L, YAHR MD, MANDELL J: Treatment of orthostatic hypotension due to autonomie failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology (1988) 38:951-956.
2. SCHIRGER A, SHEPS SG, THOMAS JE, FEALEY RD: Midodrine: a new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome. Mayo Clinic Proc. (1981) 56:429-433.
3. JANKOVIC J, GILDEN JL, HINER DC et al: Neurogenic orthostatic hypotension: a double-blind, placebocontrolled study with midodrine. Am. J. Med. (1993) 95:38-48. • Randomised trial of midodrine for neurogenic orthostatic hypotension.
4. LOW PA, GILDEN JL, FREEMAN R, SHENG KN, MCELLIGOTT MA: Efficacy of midodrine vs. placebo hi neurogenic orthostatic hypotension: a randomized, double-blind multicenter study. JAMA (1997) 277:1046-1051.
5. FOUAD-TARAZI FM, OKABE M, GOREN H: Alpha sympathomimctic treatment of autonomie insufficiency with orthostatic hypotension. Am.]. Med. (1995) 99:604-610.
6. MCTAVISH D, GOA KL: Midodrine: a review of its pharmacologie properties and therapeutic use in orthostatic hypotension and secondary hypotcnsive disorders. n(gs Ü989) 38:757-777. •• Pharmacologie overview of midodrine.
7. PERAZELLA MA: Midodrine: a new therapy for intradiah/tic hypotension. Semin. Dialysis (1997) 10:245-247.
8. CRUZ DN, MAHNENSMITH RL, PERAZELLA MA: Intradialytic hypotension: is midodrine beneficial in symptomatic hemodialysis patients? Am.J. Kidney Dis. (1997) 30:772-779. • Cross-over study of midodrine for dialysis hypotension.
9. CRUZ DN, MAHNENSMITH RL, BRICKEL HM, PERAZELLA MA: Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotension. Am.J. Kidney Dis. (1999) 35:920-926. •• Direct comparison of the two treatments for dialysishypotension.
10. CRUZ DN, MAHNENSMITH RL, BRICKEL HM, PERAZELLA MA: Midodrine is effective and safe therapy for intradialytic hypotension over 8 months of follow-up. ain. Nepbrol. (1998) 50:101-107.
11. BLOWEY DL, BALFE JW, GUPTA I, GAJAR1A MM, KOREN G: Midodrine efficacy and pharmacokinetics in a patient with recurrent intradialytic hypotension. Am. J. Kidney Dis. (1996) 28:132-136. •• Includes pharmacokinetics of midodrine in haemodialysis.
12. FLYNN.U, MITCHELL MC, CARUSO FS, MCELLIGOTT MA: Midodrine treatment for patients with hemodialysis hypotension. Clin. Nepbrol. (1996) 45:261-267.
13. FANG JT, HUANG CC: Midodrine hydrochloride in patients on hemodialysis with chronic hypotension. Renal Failure(1996) 18:253-260.
14. LIM PS, YANG CC, LI HP, LIM YT, YEH CH: Midodrine for the treatment of intradialytic hypotension. Nepbron (1997) 77:279-283.
15. PIWINSKI SE, JANKOVIC J, MCELLIGOTT MA: A comparison of postspacc-flight orthostatic intolerance to vasovagal syncope and autonomie failure and the potential use of the alpha agonist midodrine for these conditions.J. Clin. Phafmacol. (1994) 24:466-471.
16. MASKALL DD, LAM R\V: Midodrine for TCA-induced orthostatic hypotension. J. Psych. Neiirosci. (1993) 18:276-177.
17. HIRAYAMA M, WATANABE H, KOIKE Y et al.: Treatment of postprandial hypotension with selective alpha 1 and beta 1 adrenergic agonists. J. Anton. Nenviis Sys. (1993) 45:149-154.
18. RILEY AJ, RILEY EJ: Partial ejaculatory incompetence: the therapeutic effect of midodrine, an orally selective alpha-adrenoreceptor antagonist. Eur. Urol. (1982) 8:155-160.
19. GAROFALO F, LALANNA GM, NANNI G: Midodrine for female incontinence: a preliminary report. Clin. Ther. (1986) 9:44-16.
20. MARINI U, CECCHI A, VENTURINI M: Controlled clinical investigation of dimetophrine versus midodrine in the management of moderately decreased arterial blood pressure. Ctirr. Aled. Res. Opin. (1984) 9:265-274.
21. ROBERTSON D, DAVIS TL: Recent advances in the treatment of orthostatic hypotension. Neurology (.1995) 45:S26-S32.
22. STEINBACH K, WEIDINGER P: The effect of midodrine on orthostatic hypotension. Wienler Klinische Wochenschrift (1973) 85:621-624.
23. ZACHARIAH PK, BLOEDOW DC, MOVER TP, SHEPS SG, SCHIRGER A, FEALEY RD: Pharmacodynamics of midodrine, an antihypotcnsive agent. Clin. Pbarmacol. Tber. (1986) 39:586-591.
24. WRIGHT RA, KAUFMANN HC, PERERA R et al.: A double blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology (1998) 51:120-124.
25. SHERMAN RA: The pathophysiologic basis for hemodialysis-related hypotension. Semin. Dialysis (1988) 1:136-142. • Overview of dialysis hypotension.
26. CONVERSE RL, JACOBSEN TN, JOST CMT et al.: Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. / Clin. Invest. (1992) 90:1657-1665.
27. LINDBERG JS, COPLEY JB, MELTON K, WADE CE, ABRAMS J, GOODE D: Lysine vasopressin in the treatment of refractory hemodialysis-induced hypotension. Am.]. Nephrol. (1990) 10:269-275.
28. AHMAD S, ROBERTSON MT, GOLFER TA et al.: Multicenter trial of L-carnitine in maintenance hcmodialysis patients. IL Clinical and biochemical effects. Kidney /nf(1990) 38:912-918.
29. HIRSZEL IP, MARTIN RH, MIZELL MW, NOLPH KD: Urémie autonomie neuropathy: evaluation of ephedrine sulphate therapy for hemodialysis-induced hypotension. Int. Urol. Nephrol. (1976) 8:313-321.
30. VELEZ RL, WOODWARD TD, HENRICH WL: Acetate and bicarbonate hemodialysis In patients with and without autonomie dysfunction. Kidney Int. (1984) 26:59-65.
31. BARAKAT MM, NAWAD ZM, YU AW, LAU AH, ING TS, DAUGIRDAS JT: Hemodynamic effects of intradialylic food ingestion and the effects of caffeine. J. Am. Soc. Nepbrol. (1993) 3:1813-1818.
32. HENRICH WL, WOODARD TD, MCPHAUL JJ: The chronic efficacy and safety of high sodium dialysate: doubleblind crossover study. Am.J. Kidney Dis(l 982) 2:349-353.
33. DAUGIRDAS JT, AL-KUDSI RR, ING TS, NORUSIS MJ: A double-blind evaluation of sodium gradient hemodialysis. Am.J. Kepbrol. (1985) 5:163-168.
34. SHERMAN RA, RUBIN MP, CODY RP, EISINGER RP: Amelioration of hemodialysis associated hypotension by the use of cool dialysate. Am. J. Kidney Dis. (1985) 5:124-127.
35. MARGEN R, QUEREDA C, OROFINO L étal.: Hemodialysis with low temperature dialysate: a long-term experience. Nepbron (1988) 49:29-32.
36. JOST CM, AGARWAL R, KHAUR-EL-DIN T, GRAYBURN PA, VICTOR RG, HEINRICH WL: Effects of cooler temperature dialysate on hcmodynamic stability in 'problem dialysis patients. Kidney Int. (1993) 44:606-612.